Projecting the adult vaccine capacity gap in the United States: Forecasting demand and throughput through 2035
Disease and Therapeutics · 2025
DOI: 10.1016/j.dist.2025.100003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease and Therapeutics, 2025. Verfasst von Marie Beitelshees und 3 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent advances in vaccine technology – spanning mRNA platforms and combination formulations – are set to expand adult immunization options dramatically in the coming decade. Simultaneously, the U.S. faces a rapidly aging population and broadening vaccination recommendations, raising questions about whether health systems can sustain the anticipated volume of adult vaccine demand. To assess potential mismatches between vaccine demand and healthcare capacity, we developed a comprehensive Adult Vaccine Gap Analysis (AVGA) model. This model integrates (i) population forecasts and age/risk segmentation from the U.S. Census Bureau, (ii) stage-adjusted probabilities for an extensive adult vaccine pipeline (e.g., RSV, C. difficile, HIV prophylaxis), (iii) varying coverage scenarios, including a ceiling scenario of 100 % uptake, and (iv) real-world immunization benchmarks drawn from influenza and COVID-19 campaigns. We estimated annual and peak weekly volumes from 2024 through 2035 under forced seasonality versus year-round distribution, capturing how scheduling might exacerbate or mitigate throughput spikes. Under a moderate uptake scenario, total annual adult vaccine doses are projected to increase from 169 million in 2024 to 419 million by 2035; peak weekly demands exceeds ∼6 million doses/week under forced seasonality and, in high-uptake cases, approaches 23 million doses/week. A theoretical scenario of 100 % coverage reveals unprecedented daily vaccination loads, illuminating potential shortfalls in workforce, manufacturing, and fill-finish logistics. However, spreading vaccinations year-round and leveraging combination vaccines can partially alleviate throughput pressure. The projections presented are intended as directional estimates to inform planning rather than precise forecasts. These findings suggest that U.S. adult immunization demand may rapidly outpace current systems, underscoring the need for proactive workforce expansions, supply-chain strategies, and policy measures to ensure adult vaccines can be delivered at scale.
Zitieren
APA
Beitelshees, M., Hill, A., Rosemarino, N. M., & Jones, C. H. (2025). Projecting the adult vaccine capacity gap in the United States: Forecasting demand and throughput through 2035. Disease and Therapeutics. https://doi.org/10.1016/j.dist.2025.100003
Vancouver
Beitelshees M, Hill A, Rosemarino NM, Jones CH. Projecting the adult vaccine capacity gap in the United States: Forecasting demand and throughput through 2035. Disease and Therapeutics. 2025. doi:10.1016/j.dist.2025.100003
BibTeX
@article{Beitelshees2025,
author = {Beitelshees, Marie and Hill, Andrew and Rosemarino, Nick M. and Jones, Charles H.},
title = {Projecting the adult vaccine capacity gap in the United States: Forecasting demand and throughput through 2035},
journal = {Disease and Therapeutics},
year = {2025},
doi = {10.1016/j.dist.2025.100003}
}
EUVIMED